-+ 0.00%
-+ 0.00%
-+ 0.00%

Helus Pharma Q3 EPS $(1.00) Misses $(0.80) Estimate

Benzinga·02/13/2026 12:40:49
Listen to the news
Helus Pharma (NASDAQ:HELP) reported quarterly losses of $(1.00) per share which missed the analyst consensus estimate of $(0.80) by 25 percent. This is a 164.55 percent decrease over losses of $(0.38) per share from the same period last year.